Literature DB >> 19661096

Hemodilution of prostate-specific antigen levels among obese men.

Andrew Rundle, Catherine Richards, Alfred I Neugut.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661096     DOI: 10.1158/1055-9965.EPI-09-0441

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  5 in total

Review 1.  [Obesity and prostate cancer. Role of adipocytokines and clinical implications].

Authors:  M R Hoda; N Mohammed; G Theil; K Fischer; P Fornara
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  Obesity and prostate cancer detection: insights from three national surveys.

Authors:  Niyati Parekh; Yong Lin; Robert S Dipaola; Stephen Marcella; Grace Lu-Yao
Journal:  Am J Med       Date:  2010-09       Impact factor: 4.965

Review 3.  Screening for cancer with molecular markers: progress comes with potential problems.

Authors:  John A Baron
Journal:  Nat Rev Cancer       Date:  2012-04-12       Impact factor: 60.716

4.  Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies.

Authors:  A S Parker; D D Thiel; E Bergstralh; R E Carlson; L J Rangel; R W Joseph; N Diehl; R J Karnes
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-08-20       Impact factor: 5.554

Review 5.  Obesity affects the biopsy-mediated detection of prostate cancer, particularly high-grade prostate cancer: a dose-response meta-analysis of 29,464 patients.

Authors:  Meng-Bo Hu; Sheng-Hua Liu; Hao-Wen Jiang; Pei-De Bai; Qiang Ding
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.